⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for calaspargase pegol

Every month we try and update this database with for calaspargase pegol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaNCT03719105
NK-Cell Lymphom...
NK-Cell Leukemi...
Peripheral T Ce...
Methotrexate
pralatraxate,
Ifosfamide
Dexamethasone
Etoposide
calaspargase pe...
cyclophosphamid...
Doxorubicin
Prednisone
Brentuximab Ved...
1 Year - 31 YearsNew York Medical College
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)NCT06210750
T Acute Lymphob...
T Lymphoblastic...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Echocardiograph...
Lumbar Puncture
Mercaptopurine
Methotrexate
Multigated Acqu...
Navitoclax
Nelarabine
Pegaspargase
Positron Emissi...
Thioguanine
Venetoclax
Vincristine
X-Ray Imaging
18 Years - 60 YearsNational Cancer Institute (NCI)
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaNCT02981628
Recurrent B Acu...
Recurrent B Lym...
Refractory B Ac...
Refractory B Ly...
Asparaginase Er...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Diagnostic Imag...
Inotuzumab Ozog...
Leucovorin Calc...
Lumbar Puncture
Methotrexate
Pegaspargase
Vincristine
1 Year - 21 YearsChildren's Oncology Group
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaNCT05761171
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 YearsChildren's Oncology Group
Venetoclax Basket Trial for High Risk Hematologic MalignanciesNCT05292664
Myelodysplastic...
Myelodysplastic...
Myelodysplastic...
Treatment-Relat...
Therapy-Related...
Acute Lymphobla...
Acute Lymphobla...
Lymphoblastic L...
Lymphoblastic L...
Acute Leukemia ...
Acute Leukemia ...
Venetoclax
Azacitidine
Cytarabine
Methotrexate
Hydrocortisone
Leucovorin
Dexamethasone
Vincristine
Doxorubicin
Dexrazoxane
Calaspargase Pe...
Erwinia asparag...
1 Year - 40 YearsDana-Farber Cancer Institute
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaNCT03117751
Acute Lymphobla...
Acute Lymphobla...
Prednisone
Vincristine
Daunorubicin
Pegaspargase
Erwinase®
Cyclophosphamid...
Cytarabine
Mercaptopurine
Dasatinib
Methotrexate
Blinatumomab
Ruxolitinib
Bortezomib
Dexamethasone
Doxorubicin
Etoposide
Clofarabine
Vorinostat
Idarubicin
Nelarabine
Thioguanine
Asparaginase Er...
Calaspargase Pe...
1 Year - 18 YearsSt. Jude Children's Research Hospital
A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL)NCT06124157
B Acute Lymphob...
Biospecimen Col...
Blinatumomab
Bone Marrow Bio...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin
Doxorubicin
Echocardiograph...
Leucovorin
Mercaptopurine
Methotrexate
Multigated Acqu...
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Thioguanine
Vincristine
366 Days - 46 YearsNational Cancer Institute (NCI)
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)NCT05581030
Acute Lymphobla...
Hyper CVAD Prot...
Calaspargase Pe...
Rituximab
18 Years - 50 YearsH. Lee Moffitt Cancer Center and Research Institute
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyNCT03959085
B Acute Lymphob...
B Lymphoblastic...
Central Nervous...
Mixed Phenotype...
Testicular Leuk...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Bone Scan
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Leucovorin Calc...
Magnetic Resona...
Mercaptopurine
Methotrexate
Pegaspargase
Positron Emissi...
Prednisolone
Questionnaire A...
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 25 YearsChildren's Oncology Group
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and NavitoclaxNCT05192889
Refractory Acut...
Relapsed Acute ...
Venetoclax
Navitoclax
Dexamethasone
Vincristine
Calaspargase Pe...
Dasatinib
Cytarabine
Blinatumomab
Methotrexate
Mercaptopurine
Cyclophosphamid...
Etoposide
Leucovorin
Intrathecal Tri...
Pegaspargase
Erwinia asparag...
Radiation
4 Years - 30 YearsSt. Jude Children's Research Hospital
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaNCT05761171
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 YearsChildren's Oncology Group
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and NavitoclaxNCT05192889
Refractory Acut...
Relapsed Acute ...
Venetoclax
Navitoclax
Dexamethasone
Vincristine
Calaspargase Pe...
Dasatinib
Cytarabine
Blinatumomab
Methotrexate
Mercaptopurine
Cyclophosphamid...
Etoposide
Leucovorin
Intrathecal Tri...
Pegaspargase
Erwinia asparag...
Radiation
4 Years - 30 YearsSt. Jude Children's Research Hospital
Venetoclax Basket Trial for High Risk Hematologic MalignanciesNCT05292664
Myelodysplastic...
Myelodysplastic...
Myelodysplastic...
Treatment-Relat...
Therapy-Related...
Acute Lymphobla...
Acute Lymphobla...
Lymphoblastic L...
Lymphoblastic L...
Acute Leukemia ...
Acute Leukemia ...
Venetoclax
Azacitidine
Cytarabine
Methotrexate
Hydrocortisone
Leucovorin
Dexamethasone
Vincristine
Doxorubicin
Dexrazoxane
Calaspargase Pe...
Erwinia asparag...
1 Year - 40 YearsDana-Farber Cancer Institute
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaNCT05602194
B Acute Lymphob...
B Acute Lymphob...
B Acute Lymphob...
Lymphoblastic L...
Mixed Phenotype...
T Acute Lymphob...
Biospecimen Col...
Calaspargase Pe...
Levocarnitine
Pegaspargase
Quality-of-Life...
15 Years - 40 YearsChildren's Oncology Group
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaNCT03007147
Acute Lymphobla...
B Acute Lymphob...
Mixed Phenotype...
T Acute Lymphob...
Allogeneic Hema...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Dexrazoxane Hyd...
Doxorubicin
Etoposide
Filgrastim
Ifosfamide
Imatinib Mesyla...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisolone
Questionnaire A...
Therapeutic Hyd...
Thioguanine
Vincristine Sul...
1 Year - 21 YearsChildren's Oncology Group
Calaspargase Pegol in Adults With ALLNCT04817761
Acute Lymphobla...
Calaspargase pe...
22 Years - 55 YearsServier
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: